Lung epithelial cells are essential effectors of inducible resistance to pneumonia

Mucosal Immunology

Volumn 7, Issue 1, 2014, Pages 78-88

  Cleaver, J O ^a   You, D ^a   Michaud, D R ^a   Guzman Pruneda F A ^a,b   Leiva Juarez, M M ^b   Zhang, J ^a   Weill, P M ^a   Adachi, R ^a,c   Gong, L ^a   Moghaddam, S J ^a,c   Poynter, M E ^d   Tuvim, M J ^a,c   Evans, S E ^a,c,e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; TOLL LIKE RECEPTOR; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE EXPRESSION; INFECTION RESISTANCE; INNATE IMMUNITY; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; PROTEOMICS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; LEUKOCYTES; LIPOPEPTIDES; MICE; MICE, KNOCKOUT; PNEUMOCYTES; PNEUMONIA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84890942992     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.26     Document Type: Article

References (56)

1. Mizgerd, J.P. Lung infection - a public health priority. PLoS Med 3, e76 (2006).
2. Morens, D.M., Folkers, G.K. & Fauci, A.S. The challenge of emerging and re-emerging infectious diseases. Nature 430, 242-249 (2004).
3. WHO The World Health Report 2004 - Changing History (2004).
4. WHO. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull. World Health Organ. 82, 891-970 (2004).
5. Hohenthal, U. et al. Bronchoalveolar lavage in immunocompromised patients with haematological malignancy - value of new microbiological methods. Eur. J. Haematol. 74, 203-211 (2005).
6. Sharma, A. & Lokeshwar, N. Febrile neutropenia in haematological malignancies. J. Postgrad. Med. 51 (Suppl 1), S42-S48 (2005).
7. Shorr, A.F., Susla, G.M. & O'Grady, N.P. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest 125, 260-271 (2004).
8. Chang, H.Y. et al. Causes of death in adults with acute leukemia. Medicine (Baltimore) 55, 259-268 (1976).
9. Whimbey, E., Goodrich, J. & Bodey, G.P. Pneumonia in cancer patients. Cancer Treat. Res. 79, 185-210 (1995).
10. Clement, C.G. et al. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 177, 1322-1330 (2008).
11. Evans, S.E. et al. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell Mol. Biol. 42, 40-50 (2010).
12. Evans, S.E., Xu, Y., Tuvim,M.J. & Dickey, B.F. Inducible innate resistance of lung epithelium to infection. Annu. Rev. Physiol. 72, 413-435 (2010).
13. Evans, S.E. et al. Inhaled innate immune ligands to prevent pneumonia. Br. J. Pharmacol. 163, 195-206 (2011).
14. Safdar, A., Shelburne, S.A., Evans, S.E. & Dickey, B.F. Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin. Drug Saf. 8, 435-449 (2009).
15. Duggan, J.M. et al. Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J. Immunol. 186, 5916-5926 (2011).
16. Tuvim, M.J., Evans, S.E., Clement, C.G., Dickey, B.F. & Gilbert, B.E. Augmented lung inflammation protects against influenza A pneumonia. PLoS ONE 4, e4176 (2009).
17. Tuvim, M.J., Gilbert, B.E., Dickey, B.F. & Evans, S.E. Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS ONE 7, e30596 (2012).
18. Bals, R. & Hiemstra, P.S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23, 327-333 (2004).
19. Bartlett, J.A., Fischer, A.J. & McCray, P.B. Jr. Innate immune functions of the airway epithelium. Contrib. Microbiol. 15, 147-163 (2008).
20. Hippenstiel, S., Opitz, B., Schmeck, B. & Suttorp, N. Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Respir. Res. 7, 97 (2006).
21. Mizgerd, J.P. Acute lower respiratory tract infection. N. Engl. J. Med. 358, 716-727 (2008).
22. Schutte, B.C. & McCray, P.B. Jr. b-defensins in lung host defense. Annu. Rev. Physiol. 64, 709-748 (2002).
23. Hammad, H. & Lambrecht, B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 8, 193-204 (2008).
24. Strickland, D.H., Upham, J.W. & Holt, P.G. Epithelial-dendritic cell interactions in allergic disorders. Curr. Opin. Immunol. 22, 789-794 (2010).
25. Schreibelt, G. et al. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy. Cancer Immunol. Immunother. 59, 1573-1582 (2010).
26. Zanoni, I. & Granucci, F. Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors. J. Mol. Med. (Berl) 88, 873-880 (2010).
27. Seya, T., Kasamatsu, J., Azuma, M., Shime, H. & Matsumoto, M. Natural killer cell activation secondary to innate pattern sensing.. J. Innate Immun. 3, 264-273 (2011).
28. Paust, S. & von Andrian, U.H. Natural killer cell memory. Nat. Immunol. 12, 500-508 (2011).
29. Sonnenberg, G.F., Fouser, L.A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383-390 (2011).
30. Lin, S.C., Lo, Y.C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885-890 (2010).
31. Wu, H., Lo, Y.C. & Yin, Q. Structural studies of NEMO and TRAF6: implications in NF-kappaB activation. Adv. Exp. Med. Biol. 691, 89-91 (2011).
32. Valkov, E. et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals themolecular basis for signal transduction and disease protection. Proc. Natl. Acad. Sci. USA 108, 14879-14884 (2011).
33. Gay, N.J., Gangloff, M. & O'Neill, L.A. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 32, 104-109 (2011).
34. Francis, K.P. et al. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect. Immun. 69, 3350-3358 (2001).
35. Karlstrom, A., Heston, S.M., Boyd, K.L., Tuomanen, E.I. & McCullers, J.A. Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. J. Infect. Dis. 204, 1358-1366 (2011).
36. Sato,M. et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 66, 2116-2128 (2006).
37. Naeem, H., Zimmer, R., Tavakkolkhah, P. & Kuffner, R. Rigorous assessment of gene set enrichment tests. Bioinformatics 28, 1480-1486 (2012).
38. Rivals, I., Personnaz, L., Taing, L. & Potier, M.C. Enrichment or depletion of a GO category within a class of genes: which test?. Bioinformatics 23, 401-407 (2007).
39. Agusti, C. et al. Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients. Thorax 59, 1081-1088 (2004).
40. Schleimer, R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc. Am. Thorac. Soc. 1, 222-230 (2004).
41. Bowden, D.H. Cell turnover in the lung. Am. Rev.Respir.Dis. 128,S46-S48 (1983).
42. Rawlins, E.L. & Hogan, B.L. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L231-L234 (2008).
43. Mijares, L.A. et al. Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J. Immunol. 186, 7080-7088 (2011).
44. Hatanaka, E., Dermargos, A., Armelin, H.A., Curi, R. & Campa, A. Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clin. Exp. Immunol. 163, 362-367 (2011).
45. Ather, J.L. et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 187, 64-73 (2011).
46. Shah, C., Hari-Dass, R. & Raynes, J.G. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751-1757 (2006).
47. Hari-Dass, R., Shah, C., Meyer, D.J. & Raynes, J.G. Serum amyloid A protein binds to outer membrane protein A of gram-negative bacteria. J. Biol. Chem. 280, 18562-18567 (2005).
48. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL- 1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
49. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756 (2002).
50. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
51. Hou, B., Reizis, B. & DeFranco, A.L. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29, 272-282 (2008).
52. Okubo, T., Knoepfler, P.S., Eisenman, R.N. & Hogan, B.L. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 132, 1363-1374 (2005).
53. Wyde, P.R., Couch, R.B., Mackler, B.F., Cate, T.R. & Levy, B.M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 15, 221-229 (1977).
54. Gilbert, B.E.,Wyde, P.R., Ambrose, M.W.,Wilson, S.Z. & Knight, V. Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Res. 17, 33-42 (1992).
55. Clement, C.G. et al. Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice. Respir. Res. 10, 70 (2009).
56. You, Y., Richer, E.J., Huang, T. & Brody, S.L. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L1315-L1321 (2002).